Mexedia outlines its criteria for future acquisitions, without firm commitment
The company, listed on Euronext Growth Paris, detailed on 11 November 2026 the selection criteria for the companies it plans to integrate. This step follows the execution of a first tranche of €1 million of the capital increase reserved for Likan AG.
Mexedia specifies that, as of the date of the press release, it has not made any firm commitment regarding specific transactions.
Four criteria for selecting companies to integrate
Mexedia has launched a phase described as “preliminary”, the objective of which is to map the companies most consistent with its development model. Prospecting will focus mainly on companies with technological skills and “high value-added” services, complementary to those of the group.
Each opportunity will be assessed on recurring revenue, positive profitability, concrete synergies with the group's activities, and the presence of a management team capable of supporting growth.
As indicated on 29 October 2026, the proceeds of the capital increase are intended mainly to finance external growth through the acquisition of new holdings, as well as the development of subsidiaries and the strengthening of equity.
An approach backed by the capital increase and the Stantup experience
The 1,000,000 new shares issued under the first tranche were admitted to trading on Euronext Growth Paris on 5 November 2026. Shareholders had approved, on 28 October 2026, an issue reserved for Likan AG of up to €20 million, at a price of €1.00 per share.
The approach draws on the experience gained with Stantup Service, in which Mexedia holds 51% of the share capital, and pursues an approach described by the group as “progressive and selective”. The mapping work also takes into account the issue of the continuity of Italian family businesses.
According to the 17th edition of the AUB Observatory, presented in February 2026, more than one third of Italian family businesses generating at least €20 million in revenue could be affected by generational transfer over the next decade.
For Paolo Bona, Chief Executive Officer, “many valuable companies remain small because, on their own, they struggle to change scale”. Mexedia aims, in his words, “to be the group within which they can grow without losing what makes them unique”. Any potential transaction will be communicated to the market in accordance with applicable regulations.
